10.1093/sexmed/qfae018 17 GiraseT.PatilJ.TatiyaA.PatilD.PatilM
Consistent with our previous results (Figure 2) and downregulated the expression of carnitine-related (Figure 3A) and OXPHOS proteins (Figure 3B) in the skeletal muscle on day 15 of treatment initiation
Downtime varies depending on the specific services included in your protocol
The antibodies against phospho-AKT(Ser473) (4060), AKT(pan) (4691), phospho-p70S6K(Thr389) (9205), p70S6K (2708), phospho-ERK1/2(Thr202/Tyr204) (4370), ERK1/2 (4695), phospho-S6 ribosomal protein (Ser235/236) (4858), S6 ribosomal protein (2217), phospho-MDM2(Ser166) (3521), phospho-MEK1/2(Ser217/221) (9154), MEK1/2 (8727), MEK1 (12671), and cleaved caspase 3 (9664) were purchased from Cell Signaling (1:1000 or 1:2000 dilution)